232 related articles for article (PubMed ID: 2718231)
21. Viability of 5-day apheresis platelets in a citrate-plasticized bag using a new cell separator.
Simon TL; Moore RC; Sierra ER; Ferdinando B
Prog Clin Biol Res; 1990; 337():11-3. PubMed ID: 2352969
[No Abstract] [Full Text] [Related]
22. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
Wassmann A; Aulmann HM; Stangel W; Meinicke K
Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
[No Abstract] [Full Text] [Related]
23. [Comparison of thrombocyte concentrates of the cell separator AS 104 with preparations of the cell separator CS 3000 (Fenwal)].
Aulmann HM; Müller R; Zaky M; Avenarius HJ; Stangel W
Beitr Infusionsther; 1990; 26():127-30. PubMed ID: 1703811
[TBL] [Abstract][Full Text] [Related]
24. Modeling of platelet concentrate yield in continuous-flow cell separation devices.
Hester JP; Ventura GJ
J Clin Apher; 1988; 4(4):188-93. PubMed ID: 3220820
[No Abstract] [Full Text] [Related]
25. Plateletpheresis experience with the Haemonetics Blood Processor 30, the IBM Blood Processor 2997, and the Fenwal CS-3000 Blood Processor.
Kurtz SR; McMican A; Carciero R; Melaragno A; Abdu W; Katchis R; Valeri CR
Vox Sang; 1981; 41(4):212-8. PubMed ID: 7336674
[TBL] [Abstract][Full Text] [Related]
26. Storage of platelets in balanced salt solutions: a simple platelet storage medium.
Rock G; White J; Labow R
Transfusion; 1991 Jan; 31(1):21-5. PubMed ID: 1824731
[TBL] [Abstract][Full Text] [Related]
27. [Changes in the thrombocyte count and density in thrombocyte concentrates during storage with reference to thrombocyte concentration and composition of the bags].
Aulmann HM; Indorf Y; Stangel W
Beitr Infusionsther; 1990; 26():109-11. PubMed ID: 1703806
[TBL] [Abstract][Full Text] [Related]
28. The release of prion protein from platelets during storage of apheresis platelets.
Bessos H; Drummond O; Prowse C; Turner M; MacGregor I
Transfusion; 2001 Jan; 41(1):61-6. PubMed ID: 11161247
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
30. Platelet concentrates: functional considerations, storage, and quality control.
Murphy S; Schiffer CA; Katz AJ
J Clin Apher; 1983; 1(3):185-9. PubMed ID: 6546056
[No Abstract] [Full Text] [Related]
31. Evaluation of apheresis platelet concentrates stored for 5 days in PL 732 bags.
Kiraly TR; Kalish RI; Norton DF
J Clin Apher; 1987; 3(3):178-80. PubMed ID: 3558343
[TBL] [Abstract][Full Text] [Related]
32. In vitro characteristics and in vivo viability of platelets contained in granulocyte-platelet apheresis concentrate.
Snyder EL; Ezekowitz MD; Malech HL; Napychank PA; Smith EO; Kiraly T; Gardner JP; Kalish RI
Transfusion; 1987; 27(1):10-4. PubMed ID: 3810809
[TBL] [Abstract][Full Text] [Related]
33. Preparation and storage in Plasma-Lyte A of platelets collected with the cell separator CS3000 Plus equipped with the PLT30-separation and TNX6 collection chambers.
Valbonesi M; Florio G; Frisoni R; Morelli F
Int J Artif Organs; 1995 Jan; 18(1):39-44. PubMed ID: 7607757
[TBL] [Abstract][Full Text] [Related]
34. Improvement of the separation of blood by modification of separators Optipress and Biotrans Separator.
Kretschmer V; Tesche U; Richter P
Beitr Infusionsther; 1992; 30():112-21. PubMed ID: 1284685
[TBL] [Abstract][Full Text] [Related]
35. COBE Spectra Apheresis System: designs, protocols and results.
Urdahl SG
Infusionstherapie; 1989 Aug; 16 Suppl 2():30-43. PubMed ID: 2583842
[TBL] [Abstract][Full Text] [Related]
36. Effects of storage time on quantitative and qualitative platelet function after transfusion.
Rosenfeld BA; Herfel B; Faraday N; Fuller A; Braine H
Anesthesiology; 1995 Dec; 83(6):1167-72. PubMed ID: 8533908
[TBL] [Abstract][Full Text] [Related]
37. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
[TBL] [Abstract][Full Text] [Related]
38. [In-line leukocyte depletion ov thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():110-3. PubMed ID: 9417333
[TBL] [Abstract][Full Text] [Related]
39. [A new multiple blood bag system with top and bottom drainage. Comparison with the conventional multiple bag system].
Pietersz RN; Dekker WJ; Reesink HW
Beitr Infusionsther; 1990; 26():60-4. PubMed ID: 1703902
[TBL] [Abstract][Full Text] [Related]
40. A technique to reduce lymphocyte contamination of plateletapheresis products collected with a centrifugal blood cell separator.
Mintz PD; Cullis HM; Pearson TH
Transfusion; 1987; 27(2):159-61. PubMed ID: 3824472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
